|
WO2017205972A1
|
|
Systems methods and compositions for predicting metastasis in bladder cancer
|
|
CN108291262A
|
|
Gene label assesses the purposes of the therapeutic strategy of prostate cancer in diagnosis
|
|
WO2017042625A2
|
|
Molecular subtyping, prognosis and treatment of prostate cancer
|
|
US2015329915A1
|
|
Compositions and methods for classifying thyroid nodule disease
|
|
AU2014274499A1
|
|
Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
|
|
CA2915653A1
|
|
Cancer biomarkers and classifiers and uses thereof
|
|
CA2885202A1
|
|
Thyroid cancer diagnostics
|
|
WO2014028884A2
|
|
Cancer diagnostics using biomarkers
|
|
WO2010124372A1
|
|
Systems and methods for expression-based classification of thyroid tissue
|
|
EP2291553A1
|
|
Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
|
